Other OTC - Delayed Quote • USD
Acutus Medical, Inc. (AFIB)
At close: May 14 at 3:59 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Takeo Mukai | CEO & CFO | 385.01k | -- | 1981 |
Mr. Gary W. Doherty B.S. | Senior Vice President of Finance | 434.32k | -- | 1967 |
Acutus Medical, Inc.
2210 Faraday Avenue
Suite 100
Carlsbad, CA 92008
United States
- Full Time Employees:
- 230
Description
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Corporate Governance
Acutus Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- May 09, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- May 03, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Apr 25, 2024DEFA14A: Proxy StatementsSee Full Filing
- Apr 01, 202410-K: Periodic Financial ReportsSee Full Filing
- Mar 05, 20248-K: Corporate Changes & Voting MattersSee Full Filing
Upcoming Events
Aug 05, 2024 - Aug 09, 2024
Acutus Medical, Inc. Earnings Call
Related Tickers
TIVC Tivic Health Systems, Inc.
0.5000
+3.35%
NUWE Nuwellis, Inc.
0.2304
-7.17%
BIOL BIOLASE, Inc.
0.1540
-14.87%
SINT Sintx Technologies, Inc.
0.0550
+41.75%
TMCI Treace Medical Concepts, Inc.
5.0000
+10.38%
HSCS Heart Test Laboratories, Inc.
0.0791
+12.04%
HSDT Helius Medical Technologies, Inc.
1.5600
-8.24%
AEMD Aethlon Medical, Inc.
0.8501
-14.47%
NUVO Holdco Nuvo Group D.G Ltd
2.2200
-5.53%
TBIO Telesis Bio, Inc.
4.2150
+1.57%